z-logo
Premium
Blood plasma high abundant protein depletion unintentionally carries over 100 proteins
Author(s) -
SilvaCosta Licia C.,
GarciaRosa Sheila,
Smith Bradley J.,
Baldasso Paulo A.,
Steiner Johann,
MartinsdeSouza Daniel
Publication year - 2019
Publication title -
separation science plus
Language(s) - English
Resource type - Journals
ISSN - 2573-1815
DOI - 10.1002/sscp.201900057
Subject(s) - blood proteins , proteome , proteomics , shotgun , chemistry , complement system , fractionation , mass spectrometry , endocytosis , shotgun proteomics , biochemistry , immune system , biology , receptor , chromatography , immunology , gene
There is a constant interest in blood‐based protein biomarkers, which can help to improve diagnosis and treatment outcomes of multifactorial human pathologies. In this regard, proteomic studies usually employ plasma immunoaffinity fractionation to deplete the most abundant plasma proteins, due to the high dynamic concentration range of proteins. The depletion of high abundant proteins allows to obtain less abundant and, oftentimes, more interesting proteins. However, the removal of the fraction of the high abundant plasma proteins ‐ the depletome ‐ may co‐elute many unintended proteins due to protein‐protein interactions. Little data is available about the depletome and potential protein biomarkers may be lost during this process. To visualize and characterize these proteins, we analyzed the depletome of 20 plasma samples by shotgun mass spectrometry‐based proteomics. Thus, using immunoaffinity depletion followed by 2‐D liquid chromatography coupled to an ion mobility‐enhanced mass spectrometer, our analysis identified that over 100 proteins are co‐eluting with the high abundant fraction. These proteins play roles in several biological processes, such as receptor‐mediated endocytosis, complement activation, and regulation of immune response. This study supports that investigating the depletome is important in the quest for biomarkers.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here